[HTML][HTML] Computational approaches streamlining drug discovery
AV Sadybekov, V Katritch - Nature, 2023 - nature.com
Computer-aided drug discovery has been around for decades, although the past few years
have seen a tectonic shift towards embracing computational technologies in both academia …
have seen a tectonic shift towards embracing computational technologies in both academia …
Artificial intelligence in drug discovery and development
KK Mak, YH Wong, MR Pichika - Drug Discovery and Evaluation: Safety …, 2023 - Springer
This chapter comprehensively explores the pivotal role of artificial intelligence (AI) in drug
discovery and development, encapsulating its potentials, methodologies, real-world …
discovery and development, encapsulating its potentials, methodologies, real-world …
Tankbind: Trigonometry-aware neural networks for drug-protein binding structure prediction
Illuminating interactions between proteins and small drug molecules is a long-standing
challenge in the field of drug discovery. Despite the importance of understanding these …
challenge in the field of drug discovery. Despite the importance of understanding these …
Sample efficiency matters: a benchmark for practical molecular optimization
Molecular optimization is a fundamental goal in the chemical sciences and is of central
interest to drug and material design. In recent years, significant progress has been made in …
interest to drug and material design. In recent years, significant progress has been made in …
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
G Moreno‐Alcántar, P Picchetti… - Angewandte Chemie, 2023 - Wiley Online Library
The discovery of the medicinal properties of gold complexes has fuelled the design and
synthesis of new anticancer metallodrugs, which have received special attention due to their …
synthesis of new anticancer metallodrugs, which have received special attention due to their …
[HTML][HTML] Protein–ligand docking in the machine-learning era
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …
Converting nanotoxicity data to information using artificial intelligence and simulation
Decades of nanotoxicology research have generated extensive and diverse data sets.
However, data is not equal to information. The question is how to extract critical information …
However, data is not equal to information. The question is how to extract critical information …
Reinforced genetic algorithm for structure-based drug design
Abstract Structure-based drug design (SBDD) aims to discover drug candidates by finding
molecules (ligands) that bind tightly to a disease-related protein (targets), which is the …
molecules (ligands) that bind tightly to a disease-related protein (targets), which is the …
Benchmarking refined and unrefined AlphaFold2 structures for hit discovery
The recently developed AlphaFold2 (AF2) algorithm predicts proteins' 3D structures from
amino acid sequences. The open AlphaFold protein structure database covers the complete …
amino acid sequences. The open AlphaFold protein structure database covers the complete …
Targeting SARS-CoV-2 papain-like protease in the postvaccine era
While vaccines remain at the forefront of global healthcare responses, pioneering
therapeutics against SARS-CoV-2 are expected to fill the gaps for waning immunity. Rapid …
therapeutics against SARS-CoV-2 are expected to fill the gaps for waning immunity. Rapid …